311 related articles for article (PubMed ID: 6642415)
1. Experimental hyperthyroidism in man: effects on plasma lipoproteins, lipoprotein lipase and hepatic lipase.
Hansson P; Valdemarsson S; Nilsson-Ehle P
Horm Metab Res; 1983 Sep; 15(9):449-52. PubMed ID: 6642415
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipoprotein alterations in thyroid dysfunction. Roles of lipoprotein lipase, hepatic lipase and LCAT.
Valdemarsson S
Acta Endocrinol Suppl (Copenh); 1983; 255():1-52. PubMed ID: 6575562
[No Abstract] [Full Text] [Related]
3. Relations between thyroid function, hepatic and lipoprotein lipase activities, and plasma lipoprotein concentrations.
Valdemarsson S; Hansson P; Hedner P; Nilsson-Ehle P
Acta Endocrinol (Copenh); 1983 Sep; 104(1):50-6. PubMed ID: 6624364
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction--effects of treatment.
Lam KS; Chan MK; Yeung RT
Q J Med; 1986 May; 59(229):513-21. PubMed ID: 3763814
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hyperthyroidism: effects on hepatic lipase, lipoprotein lipase, LCAT and plasma lipoproteins.
Valdemarsson S; Hedner P; Nilsson-Ehle P
Scand J Clin Lab Invest; 1984 May; 44(3):183-9. PubMed ID: 6729388
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
[TBL] [Abstract][Full Text] [Related]
7. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
Nikkilä EA; Ylikahri R; Huttunen JK
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
9. Reversal of decreased hepatic lipase and lipoprotein lipase activities after treatment of hypothyroidism.
Valdemarsson S; Hedner P; Nilsson-Ehle P
Eur J Clin Invest; 1982 Oct; 12(5):423-8. PubMed ID: 6816614
[TBL] [Abstract][Full Text] [Related]
10. Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis.
Goldberg AP; Applebaum-Bowden DM; Bierman EL; Hazzard WR; Haas LB; Sherrard DJ; Brunzell JD; Huttunen JK; Ehnholm C; Nikkila EA
N Engl J Med; 1979 Nov; 301(20):1073-6. PubMed ID: 226883
[TBL] [Abstract][Full Text] [Related]
11. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne.
Bershad S; Rubinstein A; Paterniti JR; Le NA; Poliak SC; Heller B; Ginsberg HN; Fleischmajer R; Brown WV
N Engl J Med; 1985 Oct; 313(16):981-5. PubMed ID: 2931603
[TBL] [Abstract][Full Text] [Related]
12. Heparin-released plasma lipase activities, lipoprotein and apoprotein levels in young adult cyclists and sedentary men.
Giada F; Baldo-Enzi G; Balocchi MR; Zuliani G; Baroni L; Fellin R
Int J Sports Med; 1988 Aug; 9(4):270-4. PubMed ID: 3141306
[TBL] [Abstract][Full Text] [Related]
13. Alterations in plasma proteins and lipoproteins in acute myocardial infarction: effects on activation of lipoprotein lipase.
Stubbe I; Gustafson A; Nilsson-Ehle P
Scand J Clin Lab Invest; 1982 Sep; 42(5):437-44. PubMed ID: 7156856
[TBL] [Abstract][Full Text] [Related]
14. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
Stanely Mainzen Prince P; Kannan NK
J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein metabolism in postmenopausal and oophorectomized women.
Wakatsuki A; Sagara Y
Obstet Gynecol; 1995 Apr; 85(4):523-8. PubMed ID: 7898827
[TBL] [Abstract][Full Text] [Related]
17. Dyslipoproteinaemia in hypothyroidism of pituitary origin: effects of L-thyroxine substitution on lipoprotein lipase, hepatic lipase, and on plasma lipoproteins.
Valdemarsson S; Hedner P; Nilsson-Ehle P
Acta Endocrinol (Copenh); 1983 Jun; 103(2):192-7. PubMed ID: 6858552
[TBL] [Abstract][Full Text] [Related]
18. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
19. [Very low density lipoproteins and subclasses of intermediate density lipoproteins in postmenopausal women].
Berg G; Halperín H; Siseles N; Wikinski R
Medicina (B Aires); 1996; 56(5 Pt 1):479-86. PubMed ID: 9239883
[TBL] [Abstract][Full Text] [Related]
20. Abnormal fat metabolism in chronic renal failure.
Romics L; Makó J
Acta Med Acad Sci Hung; 1978; 35(3-4):233-40. PubMed ID: 227218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
